Skip to main content

Australia COVID-19 hot spot says cases fall to single digits

Australia's coronavirus hotspot of Victoria said on Monday its daily rise in new coronavirus infections fell to single digits for the first time in more than three months, as the state began winding back some restrictions.

Victoria, Australia's second-most populous state, placed nearly 5 million residents of its capital Melbourne into a hard lockdown in early August but lifted a night curfew on Sunday thanks to a steady fall in new daily case numbers.

The southeastern state reported just five new cases and three deaths from COVID-19 in the last 24 hours, after daily cases topped 700 in early August.

The two-week average of new infections in Melbourne fell below 21. Authorities have flagged that more curbs could be relaxed once average cases hit certain targets.

Prime Minister Scott Morrison on Sunday said the state should do more "in the weeks ahead to safely ease more restrictions," after state authorities promised an accelerated time table for returning to normal.

The southeastern state said 127,000 workers will be allowed to go back to work on Monday, giving a boost to the economy, a rise of 30,000 from its previous plan.

Australia has so far reported just over 27,000 cases and 875 deaths, with Victoria accounting for about 75% of infections and nearly 90% of all deaths.


Comments

Popular posts from this blog

Iran, Russia Discussing Joint Production Of COVID-19 Vaccine

Iran and Russia's sovereign wealth fund RDIF are discussing the joint production of a vaccine against COVID-19, Russian news agencies cited the Iranian ambassador to Moscow as saying on Friday. "We are holding talks, I spoke with the head of RDIF Kirill Dmitriev, our officials have held several rounds of consultations and we announced that we will co-operate," Ambassador to Moscow Kazem Jalali was cited as saying. Thus far, Russia has struck a manufacturing partnership deal with India, which is due to produce 300 million doses of the 'Sputnik-V' vaccine domestically. It is also discussing such partnerships with several other countries, including Brazil.

Increased risks of drop out for women and girls : CoronaVirus Updates

The total number of children not returning to their education after the school closures is likely to be significant. The pandemic also risks jeopardizing some of the gains made since 2001 in re-building women and girls’ education following the Taliban regime.  The COVID-19 pandemic is creating additional barriers due to risks—and students’ and parents’ anxiety about risks—associated with children returning to classrooms that are cramped, with no capacity for distancing, often cold, damp and poorly ventilated during the country’s severe winters, and have no or poor hygiene and clean water facilities. The COVID-19 pandemic is likely to drive many women and girls out of education permanently. School closures due to COVID-19, resulting increases in caregiving responsibilities for women and girls, and increases in poverty and unemployment will all make it harder for women and girls to study.  These factors combine in harmful ways with pre-existing discriminatory gender norms, o...

Russia's Covid-19 vaccine Sputnik V available to public now: State media

First batches of Russia's Covid vaccine Sputnik V have entered "civil circulation" in capital Moscow, state media reported on Thursday. While details on the process were not immediately available, Russia has repeatedly stressed on producing the vaccine at the earliest, a belief met with international scepticism. Earlier this month, the Russian health ministry had said that batches of the Covid-19 vaccine were being produced for public distribution and would be supplied to different regions soon. "The first batch of the vaccine for preventing the novel coronavirus infection, Gam-COVID-Vac (Sputnik V) developed by the Gamaleya Research Institute of Epidemiology and Microbiology of the Russian Health Ministry passed the required quality tests in the laboratories of Roszdravnadzor (the Federal Service for Surveillance in Healthcare) and was produced for civilian circulation. In the near future the supplies of the first batches of the vaccine to the regions are expected...